Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer

Christine M. Lovly, Nerina T. McDonald, Heidi Chen, Sandra Ortiz-Cuaran, Lukas C. Heukamp, Yingjun Yan, Alexandra Florin, Luka Ozretić, Diana Lim, Lu Wang, Zhao Chen, Xi Chen, Pengcheng Lu, Paul K. Paik, Ronglai Shen, Hailing Jin, Reinhard Buettner, Sascha Ansén, Sven Perner, Michael BrockmannMarc Bos, Jürgen Wolf, Masyar Gardizi, Gavin M. Wright, Benjamin Solomon, Prudence A. Russell, Toni Maree Rogers, Yoshiyuki Suehara, Monica Red-Brewer, Rudy Tieu, Elisa De Stanchina, Qingguo Wang, Zhongming Zhao, David H. Johnson, Leora Horn, Kwok Kin Wong, Roman K. Thomas, Marc Ladanyi, William Pao

Research output: Contribution to journalArticlepeer-review

178 Scopus citations

Fingerprint Dive into the research topics of 'Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds